Chi‐Wen Lo

580 citations
21 papers · 469 indexed · h-index 11

Impact in

Papers in

Chi‐Wen Lo

21 papers receiving 455 citations

Peers

Chi‐Wen Lo
Comparison fields: 5 of 92
  • Genetics 53
  • Reproductive Medicine 34
  • Immunology 82
  • Urology 23
  • Oncology 91
Replace Boris Silberberg with:
Boris Silberberg United States
Shun Xu China
Yingqi Huang China
Cristina Beltrami Italy
Peggy T. Tinkey United States
Gimano D. Amatngalim Netherlands
Marisa Halpern Israel
Nathan L. Dykes United States
Amy E. Armstrong United States
Chi‐Wen Lo relative to Boris Silberberg United States Boris Silberberg's profile →
Citations per field
00.5×4.4×
Boris Silberberg · 1×
Citations per year

Countries citing papers authored by Chi‐Wen Lo

Since Specialization
Citations

This map shows the geographic impact of Chi‐Wen Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Wen Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Wen Lo more than expected).

Fields of papers citing papers by Chi‐Wen Lo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Wen Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Wen Lo. The network helps show where Chi‐Wen Lo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chi‐Wen Lo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chi‐Wen Lo Line = papers co-authored together Chi‐Wen Lo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202139
2 202038
3 20195
4 20195
5 20198
6 20198
7 201311
8 201336
9 20116
10 201114
11 2010152
12 201010
13 200926
14 20082
15 20083
16 20075
17 200767
18 20061
19 20054
20 200419

About Chi‐Wen Lo

Chi‐Wen Lo is a scholar working on Cardiology and Cardiovascular Medicine, Genetics, Internal Medicine, Critical Care and Intensive Care Medicine and Microbiology, having authored 21 papers that have together received 469 indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (9 papers), Mesenchymal stem cell research (3 papers), Orthopaedic implants and arthroplasty (2 papers), Cardiovascular Function and Risk Factors (2 papers), Orthopedic Infections and Treatments (2 papers), Coronary Interventions and Diagnostics (2 papers), Hydraulic and Pneumatic Systems (2 papers) and Mechanical Circulatory Support Devices (2 papers). The work is most often cited by research in Genetics (53 citations), Reproductive Medicine (34 citations), Immunology (82 citations), Urology (23 citations) and Oncology (91 citations). Chi‐Wen Lo has collaborated with scholars based in Taiwan, United States and Finland. Frequent co-authors include Sheng‐Mou Hsiao, Stefan Rose‐John, Chi‐An Chen, Min‐Wei Chen, Shiuan Wang, Michael Hsiao, Lin‐Hung Wei, Tsung‐Ching Lai, Min‐Liang Kuo and Zhenyu Yao. Their work appears in journals such as ASAIO Journal, Annals of Biomedical Engineering, ACS Biomaterials Science & Engineering, IET Information Security and Tissue Engineering Part C Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026